Mon, 10 May 2021

DUBLIN, April 26, 2021 / / 7Newswire/ -- The 'Preimplantation Genetic Testing - Global Market Trajectory & Analytics' report was inserted to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the worldwide marketplace for Preimplantation Genetic Testing estimated at US$434.6 Million from the year 2020, is estimated to achieve a revised dimension of US$775.1 Million by 2027, rising at a CAGR of 8.6percent over the research period 2020-2027.

Reagents & Consumables, among those sections analyzed from the report, is estimated to capture a 9.2percent CAGR and hit US$408.5 Million At the end of the evaluation period. Following an early investigation of the company consequences of this pandemic and its triggered financial crisis, growth from the Instruments section is readjusted into a revised 7.8percent CAGR for the upcoming 7-year period.

The U.S. Market is Estimated at $128.7 Million, While China is Forecast to Grow 8% CAGR

The Preimplantation Genetic Testing marketplace from the U.S. is projected at US$128.7 Million from the year 2020. China, the world's second biggest market, is predicted to achieve a projected market size of US$134.4 Million from the year 2027 monitoring a CAGR of 8 percent within the investigation period 2020 to 2027. One of the other notable geographic markets are Japan and Canada, every forecast to increase 8% and 7% respectively within the 2020-2027 period. Within Europe, Germany is predicted to grow at roughly 7 percent CAGR.

Software & Services Segment to Document 8.3percent CAGR

In the World Software & Services section, USA, Canada, Japan, China and Europe will induce the 8.4percent CAGR estimated for this particular section. These regional markets accounting for a combined market size of US$72.9 Million in the year 2020 will achieve a projected dimension of US$128 Million from the finish of the evaluation interval. China will stay one of the fastest growing within this bunch of regional markets. Directed by countries like Australia, India, and South Korea, the marketplace in Asia-Pacific is predicted to achieve US$89.4 Million by the year 2027.

Select Competitors (Complete 34 Featured):

  • Ariosa Diagnostics
  • Bioarray S.L.
  • California Pacific Medical Center (CPMC)
  • CombiMatrix
  • CooperSurgical, Inc..
  • Genea Limited
  • Genesis Genetics
  • Great Start Genetics, Inc..

Key Issues Covered:

  • MARKET OVERVIEW
  • METHODOLOGY

    II. EXECUTIVE SUMMARY

    • Influencer Market Insights
    • World Market Trajectories
    • Effect of Covid-19 plus a Looming International Recession

  • FOCUS ON SELECT PLAYERS
  • MARKET TRENDS & DRIVERS
  • GLOBAL MARKET PERSPECTIVE
  • III. MARKET ANALYSIS

    • UNITED STATES
    • CANADA
    • JAPAN
    • CHINA
    • EUROPE
    • FRANCE
    • GERMANY
    • ITALY
    • UNITED KINGDOM
    • REST OF EUROPE
    • ASIA-PACIFIC
    • REST OF WORLD

  • COMPETITION
  • Total Firms Profiled: 34

    For more info regarding this report see https://www.researchandmarkets.com/r/a4lchk

    Media Contact:

    Research and Markets

    Laura Wood, Senior Manager

    press@researchandmarkets.com

    For E.S.T Office Hours Telephone +1-917-300-0470

    For U.S./CAN Toll Free Call +1-800-526-8630

    For GMT Office Hours Telephone +353-1-416-8900

    U.S. Fax: 646-607-1904

    Fax (external U.S.): +353-1-481-1716

    SOURCE Research and Markets

    Associated Links

    http://www.researchandmarkets.com

    More New Hampshire News

    Access More

    Sign up for New Hampshire State News

    a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!